SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 740.00 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 544.66 |
| Book Value / Share | 7.26 |
| Price / Book | n/a |
| NCAV ($M) | -417.81 |
| NCAV / Share | -5.57 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.97 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -1.59 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.40 |
| Current Ratio | 1.79 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 397.28 |
| Assets | 1,359.75 |
| Liabilities | 815.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,153,917 | 10,671,434 | 29.55 | |
| 5,925,512 | 1,961,499 | 302.09 | |
| 2,580,815 | 1,419,948 | 181.75 | |
| 4,051,895 | 1,584,473 | 255.73 | |
| 5,248,568 | 2,239,491 | 234.36 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BPMC – Blueprint Medicines Corporation | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. |